TetraQ is an Agilex Biolabs company and a Brisbane-based provider of bioanalytical and in-life services for new drug and vaccine products. Our facility has NATA recognition for compliance with the OECD Principles of Good Laboratory Practice (GLP).
Our bioanalytical facility is located at the Royal Brisbane and Women’s Hospital, and our in-life studies are run in a custom unit at the St Lucia campus of The University of Queensland. These two arms offer coordinated support for clients bringing pharmaceutical products to market. Contact Us
years of operation
TetraQ is an Agilex Biolabs company providing preclinical and clinical support to industry, academia and non-profits.
TetraQ’s bioanalytical facility determines small molecule and protein concentrations in matrices including plasma, serum, urine and tissue homogenates. We can develop and validate methods to support pharmacokinetic (PK) sample analysis for both preclinical and clinical studies.
TetraQ provides customized preclinical packages ranging from early-phase screening to formal GLP studies capable of supporting first-in-human trials. Options include acute or repeat dosing and sub-acute or chronic studies as well as toxicokinetic analysis.
Our staff are experienced with multiple modes of dosing. Study management and data collection are supported by Provantis software for the highest quality. Contact Us
TetraQ operates a custom in-life facility at the St Lucia campus of The University of Queensland, offering preclinical trials for novel drugs and vaccines.